Cholesterol drug studied as abortion pill booster
NCT ID NCT05342974
First seen Apr 22, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This small pilot study tested whether the cholesterol drug atorvastatin, followed by misoprostol, can safely end an early pregnancy. Nine participants at 35-49 days of pregnancy took atorvastatin daily for a week, then a dose of misoprostol. Ultrasounds and hormone checks tracked whether the pregnancy stopped progressing. The goal was to see if this combination could work as an alternative to the standard two-pill abortion regimen.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABORTION EARLY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Planned Parenthood Association of Utah
Salt Lake City, Utah, 84102, United States
Conditions
Explore the condition pages connected to this study.